$SPCX

SpaceX reclaims $135 IPO price in premarket trade Monday

SpaceX’s stock (SPCX) rose about 2.3% in Monday premarket to around $136.20, reclaiming its $135 IPO price. The article cites an Argus upgrade to Buy with a $160 target, limited insider selling after Aug. 6 unlocks, and SpaceX and Tesla’s planned $16.8B “Terafab” chip complex in Texas. It also notes Q2 2026 revenue of $7.814B and higher capex.

Original reporting
Published Aug 10, 2026, 12:47 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 1:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMarket movers
Primary signal
$SPCX
Bullish
medium confidence
Mentioned
$SPCX
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$SPCXBullishMed
01

Why it matters

SPCX is attempting to consolidate above its $135 IPO reference level as investors digest earnings details (strong revenue growth but heavy AI capex), an analyst upgrade, and a major announced semiconductor fabrication complex.

02

Market read

Traders get a near-term setup for SPCX around the IPO price level, with concrete catalysts (upgrade, insider-selling outcome, Terafab) and explicit volatility risks (share unlocks, peer earnings, macro inflation).

03

What to watch

Upcoming lockup tranches through Dec 8 and the after-hours earnings from RKLB and ASTS could quickly change the risk premium, making any early strength fragile.

Relevance 7/10Novelty 5/10Timing: pre-market Monday, ahead of the session and peer earnings after the close

Background

The article frames SPCX’s post-IPO trading as a volatile, AI-compute-driven story that sold off after Aug 4 results, then began recovering into Monday.

Company-level read

Ticker impact

$SPCXBullishMedium confidence
Context

SpaceX shares are up about 2.3% premarket to $136.20, reclaiming the $135 IPO price after the Aug 4 earnings-driven dip.

Expected impact

Bias to continued strength early Monday, with elevated intraday swings as supply from unlocked shares and upcoming peer earnings can reverse sentiment.

Evidence & confidence

The article ties the move to specific, time-relevant drivers: an Argus upgrade with a $160 target, reduced-than-feared insider selling, and a newly announced $16.8B Terafab semiconductor complex in Texas, while also warning that ongoing unlock tranches through Dec 8 likely keep volatility elevated.

Market effects

Space/AI compute narrative remains a key driver for high-multiple space names, so peer earnings (RKLB, ASTS) may spill over into SPCX sentiment.

Texas semiconductor buildout narrative could reinforce investor focus on AI infrastructure capex themes.

Macro risk from the week’s inflation data could pressure high-multiple tech-like growth valuations, affecting SPCX’s ability to sustain gains.

Counterpoint

The stock’s rebound may be more about supply dynamics and sentiment than fundamentals, since AI-related capex surged and could pressure near-term free cash flow.

Key entities

  • SpaceX

    Subject of the article, with shares reclaiming the $135 IPO price in premarket trade and catalysts tied to earnings, analyst upgrades, and the Terafab announcement.

  • Terafab semiconductor fabrication complex

    $16.8B facility in Grimes County, Texas, positioned as AI compute infrastructure with potential multi-phase investment.

  • Argus Research

    Upgraded SPCX to Buy and set a $160 price target, supporting the premarket bid.

  • Vanda Research

    Reported net retail buying of $22.7M in the first hour after the post-earnings sell-off day.

  • ActivTrades (Carolane de Palmas)

    Warned that unlocked shares likely keep volatility elevated through scheduled tranches into December.

Related articles

$SPCXMed

Why SpaceX Stock Plunged Despite a Strong Q2 Earnings Beat

SpaceX shares fell after its Aug. 4 Q2 results, with a 13.61% drop on Aug. 5. The focus was $18.4B quarterly capex, mostly for AI infrastructure, plus concerns around insider lockup expiration. Q2 revenue rose 92% to $7.81B and net loss narrowed to $541M. Analysts cited AI investment returns; Argus raised to Buy with $160 target and JPMorgan to Overweight with $240.

$TSLAMedAI 8/10

Tesla and SpaceX Committed $16.8 Billion to One Chip Plant. Tesla's Entire Annual Profit Is $3.8 Billion.

Tesla and SpaceX said Aug. 6 they will jointly spend $16.8 billion on the first phase of Terafab, a semiconductor plant in Grimes County, Texas. Tesla cited $3.8 billion net income over the past 12 months and about $43.5 billion cash and investments. The project is described as multiphase, potentially up to $119 billion, with chips for Tesla robots/Cybercab and SpaceX data centers.

$SPCXMed

SpaceX Stock Stalls Around IPO Price: What's Going On? - SpaceX (NASDAQ:SPCX)

SpaceX (NASDAQ:SPCX) shares traded near $132.90, down 0.17% on Monday, after a lockup expiration of 911.5 million insider-held shares that did not trigger expected selling. Morgan Stanley’s Adam Jonas kept an Overweight rating and set a mid-2027 $300 target. Vanda Research said retail turned net sellers by $4.5 million. SpaceX Q2 revenue was $7.81B, up 92% YoY, with a 9-cent per-share loss and $100B cash.

$SPCXMedAI 8/10

SpaceX Just Reported Earnings. Here's What History Says Happens Next.

SpaceX (SPCX) reported Q2 results as a newly public company. Total revenue rose 92% to $7.8B. Connectivity revenue increased 66% to $4.3B with operating income up 79% to $1.6B. The AI segment revenue grew 247% to $2.6B but operating losses were $1.3B. Operating losses widened to $542M. Investors will watch capex efficiency and AI revenue scaling.